/

surrozen

Developing Wnt pathway-modulating therapeutics for tissue repair.

BiotechnologyPharmaceuticals surrozen.com ↗

Company facts

Founded: 2015
Employees: 44
Headquarters: United States
Type: Public
Listed: Nasdaq: SRZN